Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126065101 | 12606510 | 1 | I | 20160727 | 20160729 | 20160729 | EXP | US-FRESENIUS KABI-FK201604858 | FRESENIUS KABI | WALLACE K,FILIPEK R,LA HOZ R,WILLIAMSON J. SUBTHERAPEUTIC VORICONAZOLE CONCENTRATIONS ASSOCIATED WITH CONCOMITANT DEXAMETHASONE: CASE REPORT AND REVIEW OF THE LITERATURE. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS 2016;441-443. | 84.00 | YR | M | Y | 60.00000 | KG | 20160729 | PH | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126065101 | 12606510 | 1 | PS | DEXAMETHASONE INJECTION (manufacturer unknown) | DEXAMETHASONE | 1 | Oral | Y | U | UNKNOWN | 84916 | 4 | MG | UNKNOWN | Q8H | ||||
| 126065101 | 12606510 | 2 | SS | VORICONAZOLE. | VORICONAZOLE | 1 | Intravenous (not otherwise specified) | 0 | 400 | MG | Q12H | ||||||||
| 126065101 | 12606510 | 3 | SS | VORICONAZOLE. | VORICONAZOLE | 1 | Unknown | 0 | 250 | MG | Q12H | ||||||||
| 126065101 | 12606510 | 4 | SS | VORICONAZOLE. | VORICONAZOLE | 1 | Oral | 0 | 200 | MG | Q12H | ||||||||
| 126065101 | 12606510 | 5 | C | CEFEPIME | CEFEPIME HYDROCHLORIDE | 1 | Unknown | 0 | |||||||||||
| 126065101 | 12606510 | 6 | C | VANCOMYCIN | VANCOMYCIN | 1 | Unknown | 0 | |||||||||||
| 126065101 | 12606510 | 7 | C | METRONIDAZOLE. | METRONIDAZOLE | 1 | Unknown | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126065101 | 12606510 | 1 | Brain oedema |
| 126065101 | 12606510 | 2 | Abscess fungal |
| 126065101 | 12606510 | 5 | Purulent discharge |
| 126065101 | 12606510 | 6 | Purulent discharge |
| 126065101 | 12606510 | 7 | Purulent discharge |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126065101 | 12606510 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126065101 | 12606510 | Drug interaction | |
| 126065101 | 12606510 | Drug level below therapeutic | |
| 126065101 | 12606510 | Treatment failure |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |